FDA: 4 companies in cities within Orange County received 10 citations in Q1

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA
Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA
0Comments

There were four companies in cities associated with Orange County that received FDA citations as a result of four inspections conducted in the county over the first quarter of 2026, according to the U.S. Food and Drug Administration (FDA).

This is a 100% increase over the number of companies cited in the previous quarter.

The citations in the county include:

  • Records needed to demonstrate compliance with applicable regulatory requirements have not been established and maintained.
  • Records to provide evidence of conformity to requirements and the effective operation of the quality management system have not been maintained.
  • The necessary competence for personnel performing work that affects product quality has not been determined.

Most of the companies cited were involved in the Food and Cosmetics sector.

All of the companies cited should take voluntary actions to correct their managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Companies Located within Orange County Cities and the Citations They Received in Q1
Company Name Area of Business Inspection Date Issue Cited
Atlantic Aviation Orlando Executive, LLC Food and Cosmetics 03/06/2026 Prevention of contamination
Douce France Bakery, Inc. Food and Cosmetics 02/26/2026 Process preventive controls – Appropriate (Adequate)
Douce France Bakery, Inc. Food and Cosmetics 02/26/2026 Supply-chain program – Assurance (Adequate)
Prodalim USA, Inc. Food and Cosmetics 02/20/2026 Sanitation monitoring
The Side Lyer Company, LLC Devices 03/12/2026 QMS process records not established or maintained
The Side Lyer Company, LLC Devices 03/12/2026 Records of conformity and QMS operations not maintained
The Side Lyer Company, LLC Devices 03/12/2026 Necessary personnel competence not determined
The Side Lyer Company, LLC Devices 03/12/2026 Records of risk management activities in product realization not maintained
The Side Lyer Company, LLC Devices 03/12/2026 Requirements for design and development changes not met before implementation
The Side Lyer Company, LLC Devices 03/12/2026 Procedures for purchasing process not documented

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Orlando’s Medicaid spending on Prosthetic Procedures jumps to $714,349 in 2024

In 2024, Orlando Medicaid providers invoiced $714,349 for Prosthetic Procedures, representing a 2645637% increase from the prior year.

Maxwell A. Frost, U.S. Representative of Florida's 10th Congressional District

Rep. Frost files bill in House to abolish immigration detainers

U.S. Rep. Maxwell Frost has proposed legislation in the House targeting the elimination of immigration detainers and associated law enforcement agreements.

Mayor Buddy Dyer, City of Orlando

Pulse Memorial project reaches 60% design milestone in Orlando

Orlando officials report that design work on the Pulse Memorial has reached its 60% milestone. Plans now feature an indoor Visitor Pavilion focused on storytelling and remembrance of those affected by the tragedy. Construction is scheduled to begin in September 2026.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Orlando Standard.